CT
NVO

Colonial Trust’s Novo Nordisk NVO Stock Holding History

Colonial Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1K Buy
899
+171
+23% +$7.35K 0.01% 547
2026
Q1 		$26.8K Sell
728
-65
-8% -$3.08K ﹤0.01% 627
2025
Q4 		$40.3K Sell
793
-71
-8% -$3.63K 0.01% 579
2025
Q3 		$47.9K Buy
864
+32
+4% +$1.87K 0.01% 553
2025
Q2 		$57.4K Sell
832
-204
-20% -$13.9K 0.01% 523
2025
Q1 		$71.9K Sell
1,036
-1,164
-53% -$96.1K 0.01% 473
2024
Q4 		$189K Sell
2,200
-770
-26% -$83.3K 0.03% 318
2024
Q3 		$354K Buy
2,970
+513
+21% +$68.4K 0.05% 215
2024
Q2 		$351K Hold
2,457
– – 0.06% 189
2024
Q1 		$316K Sell
2,457
-47
-2% -$5.59K 0.06% 205
2023
Q4 		$259K Buy
2,504
+976
+64% +$96.5K 0.05% 223
2023
Q3 		$139K Sell
1,528
-492
-24% -$43.3K 0.03% 286
2023
Q2 		$163K Buy
2,020
+1,428
+241% +$117K 0.04% 265
2023
Q1 		$47.1K Sell
592
-14
-2% -$993 0.01% 468
2022
Q4 		$41K Buy
+606
New +$35.5K 0.01% 473

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Colonial Trust's NVO Position: Q2 2026 in Review

Colonial Trust increased its Novo Nordisk (NVO) stake by 23% in Q2 2026, buying an estimated $7.35K and bringing the position to 899 shares worth $43.1K. The position accounts for 0.01% of the portfolio, ranked #547.

Colonial Trust first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $354K in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Colonial Trust held 899 shares of Novo Nordisk worth $43.1K as of Q2 2026.
  • Colonial Trust bought 171 Novo Nordisk shares in Q2 2026, an estimated $7.35K.
  • Novo Nordisk made up 0.01% of Colonial Trust's portfolio in Q2 2026, its #547 holding.
  • Colonial Trust first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
  • Colonial Trust's Novo Nordisk position peaked at $354K in Q3 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.